April 30, 2026 13:30 ET | Source: CROSSJECT CROSSJECT
RAPPORT FINANCIER 2025
Pièces jointes
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
DIJON, France – 25 mars 2026 (06.00 PM CET) – CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), the specialty pharmaceuticals company developing emergency medicines based on its proprietary ZENEO®...
